Additionally, while NQO1:CAT was not directly measured, inhibition of catalase and GSH did not lead to sensitization of KEAP1-mutated NSCLC during β-lapachone treatment, while inhibition of TXNRD and SOD1 sensitized cancers [29]. This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.